264 related articles for article (PubMed ID: 23917144)
1. Inflammation-related DNA damage and expression of CD133 and Oct3/4 in cholangiocarcinoma patients with poor prognosis.
Thanan R; Pairojkul C; Pinlaor S; Khuntikeo N; Wongkham C; Sripa B; Ma N; Vaeteewoottacharn K; Furukawa A; Kobayashi H; Hiraku Y; Oikawa S; Kawanishi S; Yongvanit P; Murata M
Free Radic Biol Med; 2013 Dec; 65():1464-1472. PubMed ID: 23917144
[TBL] [Abstract][Full Text] [Related]
2. Characterization of CD133+ parenchymal cells in the liver: histology and culture.
Yoshikawa S; Zen Y; Fujii T; Sato Y; Ohta T; Aoyagi Y; Nakanuma Y
World J Gastroenterol; 2009 Oct; 15(39):4896-906. PubMed ID: 19842219
[TBL] [Abstract][Full Text] [Related]
3. CD133 expression is a potential prognostic indicator in intrahepatic cholangiocarcinoma.
Shimada M; Sugimoto K; Iwahashi S; Utsunomiya T; Morine Y; Imura S; Ikemoto T
J Gastroenterol; 2010 Aug; 45(8):896-902. PubMed ID: 20379837
[TBL] [Abstract][Full Text] [Related]
4. Nitrative DNA damage and Oct3/4 expression in urinary bladder cancer with Schistosoma haematobium infection.
Ma N; Thanan R; Kobayashi H; Hammam O; Wishahi M; El Leithy T; Hiraku Y; Amro el-K; Oikawa S; Ohnishi S; Murata M; Kawanishi S
Biochem Biophys Res Commun; 2011 Oct; 414(2):344-9. PubMed ID: 21951846
[TBL] [Abstract][Full Text] [Related]
5. Nitrative and oxidative DNA damage in intrahepatic cholangiocarcinoma patients in relation to tumor invasion.
Pinlaor S; Sripa B; Ma N; Hiraku Y; Yongvanit P; Wongkham S; Pairojkul C; Bhudhisawasdi V; Oikawa S; Murata M; Semba R; Kawanishi S
World J Gastroenterol; 2005 Aug; 11(30):4644-9. PubMed ID: 16094703
[TBL] [Abstract][Full Text] [Related]
6. CD133: a potential indicator for differentiation and prognosis of human cholangiocarcinoma.
Fan L; He F; Liu H; Zhu J; Liu Y; Yin Z; Wang L; Guo Y; Wang Z; Yan Q; Huang G
BMC Cancer; 2011 Jul; 11():320. PubMed ID: 21798073
[TBL] [Abstract][Full Text] [Related]
7. Decreased expression of TFPI-2 correlated with increased expression of CD133 in cholangiocarcinoma.
Chu X; Zhao P; Lv Y; Liu L
Int J Clin Exp Pathol; 2015; 8(1):328-36. PubMed ID: 25755719
[TBL] [Abstract][Full Text] [Related]
8. CD133+ subpopulation of the HT1080 human fibrosarcoma cell line exhibits cancer stem-like characteristics.
Feng BH; Liu AG; Gu WG; Deng L; Cheng XG; Tong TJ; Zhang HZ
Oncol Rep; 2013 Aug; 30(2):815-23. PubMed ID: 23708735
[TBL] [Abstract][Full Text] [Related]
9. High expression of octamer-binding transcription factor 4A, prominin-1 and aldehyde dehydrogenase strongly indicates involvement in the initiation of lung adenocarcinoma resulting in shorter disease-free intervals.
Cortes-Dericks L; Galetta D; Spaggiari L; Schmid RA; Karoubi G
Eur J Cardiothorac Surg; 2012 Jun; 41(6):e173-81. PubMed ID: 22529186
[TBL] [Abstract][Full Text] [Related]
10. Identification of hepatic stem/progenitor cells in canine hepatocellular and cholangiocellular carcinoma.
Cogliati B; Aloia TP; Bosch RV; Alves VA; Hernandez-Blazquez FJ; Dagli ML
Vet Comp Oncol; 2010 Jun; 8(2):112-21. PubMed ID: 20579324
[TBL] [Abstract][Full Text] [Related]
11. Mechanism of NO-mediated oxidative and nitrative DNA damage in hamsters infected with Opisthorchis viverrini: a model of inflammation-mediated carcinogenesis.
Pinlaor S; Hiraku Y; Ma N; Yongvanit P; Semba R; Oikawa S; Murata M; Sripa B; Sithithaworn P; Kawanishi S
Nitric Oxide; 2004 Sep; 11(2):175-83. PubMed ID: 15491850
[TBL] [Abstract][Full Text] [Related]
12. DNA Damage in CD133-Positive Cells in Barrett's Esophagus and Esophageal Adenocarcinoma.
Thanan R; Ma N; Hiraku Y; Iijima K; Koike T; Shimosegawa T; Murata M; Kawanishi S
Mediators Inflamm; 2016; 2016():7937814. PubMed ID: 27069317
[TBL] [Abstract][Full Text] [Related]
13. Strong expression of CD133 is associated with increased cholangiocarcinoma progression.
Leelawat K; Thongtawee T; Narong S; Subwongcharoen S; Treepongkaruna SA
World J Gastroenterol; 2011 Mar; 17(9):1192-8. PubMed ID: 21448425
[TBL] [Abstract][Full Text] [Related]
14. Non-small cell lung cancer cells expressing CD44 are enriched for stem cell-like properties.
Leung EL; Fiscus RR; Tung JW; Tin VP; Cheng LC; Sihoe AD; Fink LM; Ma Y; Wong MP
PLoS One; 2010 Nov; 5(11):e14062. PubMed ID: 21124918
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathologic significance of combined hepatocellular-cholangiocarcinoma with stem cell subtype components with reference to the expression of putative stem cell markers.
Ikeda H; Harada K; Sato Y; Sasaki M; Yoneda N; Kitamura S; Sudo Y; Ooi A; Nakanuma Y
Am J Clin Pathol; 2013 Sep; 140(3):329-40. PubMed ID: 23955451
[TBL] [Abstract][Full Text] [Related]
16. Cord blood CD133 cells define an OV6-positive population that can be differentiated in vitro into engraftable bipotent hepatic progenitors.
Crema A; Ledda M; De Carlo F; Fioretti D; Rinaldi M; Marchese R; Sanchez M; Giuliani M; Arena V; Durrbach A; Brunetti E; Haas C; Ponzetto A; Lisi A; Carloni G
Stem Cells Dev; 2011 Nov; 20(11):2009-21. PubMed ID: 21291316
[TBL] [Abstract][Full Text] [Related]
17. Prolonged oxidative stress down-regulates Early B cell factor 1 with inhibition of its tumor suppressive function against cholangiocarcinoma genesis.
Armartmuntree N; Murata M; Techasen A; Yongvanit P; Loilome W; Namwat N; Pairojkul C; Sakonsinsiri C; Pinlaor S; Thanan R
Redox Biol; 2018 Apr; 14():637-644. PubMed ID: 29169115
[TBL] [Abstract][Full Text] [Related]
18. Hypoxia induces CD133 expression in human lung cancer cells by up-regulation of OCT3/4 and SOX2.
Iida H; Suzuki M; Goitsuka R; Ueno H
Int J Oncol; 2012 Jan; 40(1):71-9. PubMed ID: 21947321
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathological study on cholangiolocellular carcinoma suggesting hepatic progenitor cell origin.
Komuta M; Spee B; Vander Borght S; De Vos R; Verslype C; Aerts R; Yano H; Suzuki T; Matsuda M; Fujii H; Desmet VJ; Kojiro M; Roskams T
Hepatology; 2008 May; 47(5):1544-56. PubMed ID: 18393293
[TBL] [Abstract][Full Text] [Related]
20. iNOS-dependent DNA damage via NF-kappaB expression in hamsters infected with Opisthorchis viverrini and its suppression by the antihelminthic drug praziquantel.
Pinlaor S; Hiraku Y; Yongvanit P; Tada-Oikawa S; Ma N; Pinlaor P; Sithithaworn P; Sripa B; Murata M; Oikawa S; Kawanishi S
Int J Cancer; 2006 Sep; 119(5):1067-72. PubMed ID: 16570287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
